Family in shock after receiving a $10k, 26-year-old medical bill
(By Alia Paavola for Becker’s Hospital Review) A North Dakota family is in disbelief after receiving a roughly $10,000, 26-year-old
Read More
Legal Actions/Court Decisions
Insys founder arrested and charged in alleged conspiracy to bribe doctors
(By Ike Swetlitz for STAT) The founder of the pharmaceutical company Insys Therapeutics Inc. was arrested Thursday on charges of
Read MoreFederal Judge Denies Bid To Force Feds To Resume ACA Subsidies
(By Ngoc Nguyen for California Healthline produced by Kaiser Health News) SAN FRANCISCO — A federal judge Wednesday denied a
Read MoreAbsent Federal Action, States Take The Lead On Curbing Drug Costs
(By Shefali Luthra for Kaiser Health News) Lawmakers in Maryland are daring to legislate where their federal counterparts have not:
Read MoreTo Wage War On Superbugs, FDA Clears Way For Scope With A Disposable Piece
(By Chad Terhune for California Healthline produced by Kaiser Health News) Seeking to prevent superbug outbreaks, federal health officials said
Read More22 healthcare bankruptcies so far in 2017
(By Ayla Ellison for Becker’s Hospital Review) From reimbursement landscape challenges to dwindling patient volumes, many factors lead hospitals and
Read MoreFDA approves 1st app to treat substance use disorders
The U.S. Food and Drug Administration has permitted the startup Pear Therapeutics to market the first medical app aiding in
Read MoreFDA Moves To Guard Against Abuse Of ‘Orphan Drug’ Program
The Food and Drug Administration is changing the way it approves medicines known as “orphan drugs” after revelations that drugmakers
Read MoreAetna faces class-action lawsuit after exposing customers’ HIV status
(By Ayla Ellison for Becker’s Hospital Review) Legal groups Monday filed a class-action lawsuit against Aetna, alleging the health insurer
Read MoreFDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments
(By Rob Stein for NPR) The Food and Drug Administration is cracking down on “unscrupulous” clinics selling unproven and potentially
Read More